TRMT61A and inflammatory bowel disease: The observed decrease in IL-22-producing ILC3s in Trmt61aΔRorc mice correlates with reduced TRMT61A expression levels, suggesting that similar mechanisms may operate in IBD, where inflammation could suppress TRMT61A expression, thereby diminishing ILC3 functionality.